obidoxime chloride has been researched along with sarin in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (19.44) | 18.7374 |
1990's | 4 (11.11) | 18.2507 |
2000's | 15 (41.67) | 29.6817 |
2010's | 10 (27.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fonnum, F; Lund-Karlsen, R | 1 |
Bajgar, J; Hrdina, V; Jakl, A; Patocka, J | 1 |
Alioth-Streichenberg, CM; Hofmann, W; Hopff, WH; Niederhauser, A; Portmann, R; Waser, PG | 1 |
Alioth-Streichenberg, CM; Bodmer, DM; Waser, PG | 1 |
Clement, JG; Shiloff, JD | 1 |
Artursson, E; Bucht, G; Puu, G | 1 |
Hopff, WH; Riggio, G; Waser, PG | 1 |
Caratsch, CG; Waser, PG | 1 |
Busker, RW; Melchers, BP; van der Wiel, HJ; van Helden, HP; Zijlstra, JJ | 1 |
Bajgar, J; Kassa, J | 1 |
Eyer, P; Kiderlen, D; Szinicz, L; Thiermann, H; Worek, F | 1 |
Eyer, P; Reiter, G; Szinicz, L; Worek, F | 1 |
HEILBRONN, E; TOLAGEN, B | 1 |
Kassa, J; Kuca, K | 1 |
Cabal, J; Kassa, J; Kuca, K | 2 |
Becker, G; Gutzeit, D; Kawan, A; Szinicz, L; Worek, F | 1 |
Bajgar, J; Jun, D; Kuca, K | 1 |
Antonijevic, B; Stojiljkovic, MP | 1 |
Bumm, R; Eckert, S; Eyer, P; Herkert, N; Thiermann, H; Weber, G; Worek, F | 1 |
Acharya, J; Dubey, DK; Gupta, AK; Mazumder, A | 1 |
Jun, D; Kuca, K | 1 |
Jun, D; Koleckar, V; Kuca, K; Marek, J; Picha, J | 1 |
Koplovitz, I; Maxwell, DM; Sweeney, RE; Worek, F | 1 |
Aurbek, N; Herkert, NM; Koller, M; Thiermann, H; Worek, F | 2 |
Acharya, J; Dubey, DK; Raza, SK | 1 |
Karasova, JZ; Kassa, J; Misik, J | 1 |
Brecht, KM; Maxwell, DM; Sweeney, RE | 1 |
Horova, A; Kassa, J; Matouskova, L; Musilek, K; Sepsova, V | 1 |
Koller, M; Thiermann, H; Wille, T; Worek, F | 1 |
Chen, J; Guo, L; Tang, J; Xie, J; Xie, Y; Xu, B; Yan, L | 1 |
Acharya, BN; Acharya, J; Bhalerao, U; Karade, HN; Raviraju, G; Valiveti, AK | 1 |
Bird, M; Green, AC; Kassa, J; Tattersall, JEH; Timperley, CM; Williams, RL | 1 |
Cochrane, L; Cornelissen, AS; Joosen, MJA; Klaassen, SD; Shearer, JD; Skiadopoulos, MH; van Groningen, T; Verheij, E | 1 |
Agnusdei, M; Belinskaya, T; Borriello, M; Brindisi, M; Butini, S; Campiani, G; Catalanotti, B; Fattorusso, C; Fiorini, I; Gemma, S; Nacci, V; Novellino, E; Panico, A; Persico, M; Ros, S; Saxena, A | 1 |
1 review(s) available for obidoxime chloride and sarin
Article | Year |
---|---|
Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Topics: Acetylcholinesterase; Antidotes; Chemical Warfare Agents; Cholinesterase Reactivators; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Insecticides; Obidoxime Chloride; Organophosphate Poisoning; Organothiophosphorus Compounds; Oximes; Pralidoxime Compounds; Sarin; Trimedoxime | 2007 |
35 other study(ies) available for obidoxime chloride and sarin
Article | Year |
---|---|
The effect of locally applied cholinesterase inhibitors and oximes on the acetylcholinesterase activity in different parts of the guinea-pig eye.
Topics: Acetylcholinesterase; Animals; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Eye; Guinea Pigs; Isoflurophate; Obidoxime Chloride; Oculomotor Muscles; Oximes; Paraoxon; Sarin | 1976 |
Antidotal therapy and changes of acetylcholinesterase activity following isopropyl methylphosphonofluoridate intoxication in mice.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Brain; Dose-Response Relationship, Drug; Drug Synergism; Male; Mice; Obidoxime Chloride; Organophosphate Poisoning; Oximes; Sarin; Trimedoxime | 1975 |
Interaction of obidoxime with sarin in aqueous solution.
Topics: Chromatography, Thin Layer; Drug Interactions; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Obidoxime Chloride; Phosphorus; Sarin; Solutions; Spectrophotometry, Ultraviolet | 1992 |
Pharmacokinetics and pharmacodynamics of obidoxime in sarin-poisoned rats.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Female; Obidoxime Chloride; Rats; Receptors, Cholinergic; Receptors, Nicotinic; Sarin | 1991 |
Comparison of serum concentrations of the acetylcholinesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in rats.
Topics: Acetylcholinesterase; Animals; Male; Obidoxime Chloride; Organophosphate Poisoning; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Rats; Rats, Inbred Strains; Sarin | 1987 |
Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime.
Topics: Acetylcholinesterase; Caudate Nucleus; Cholinesterase Reactivators; Edrophonium; Humans; Muscles; Obidoxime Chloride; Organophosphates; Organothiophosphorus Compounds; Oximes; Pyridinium Compounds; Sarin; Soman; Stereoisomerism | 1986 |
Sarin poisoning in guinea pigs compared to reactivation of acetylcholinesterase in vitro as a basis for therapy.
Topics: Acetylcholinesterase; Animals; Cholinesterase Reactivators; Female; Guinea Pigs; In Vitro Techniques; Lethal Dose 50; Male; Obidoxime Chloride; Organophosphate Poisoning; Sarin; Species Specificity | 1984 |
Effects of obidoxime chloride on native and sarin-poisoned frog neuromuscular junctions.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Reactivators; Iontophoresis; Membrane Potentials; Motor Endplate; Neuromuscular Junction; Obidoxime Chloride; Oximes; Rana temporaria; Receptors, Cholinergic; Sarin; Sodium Chloride | 1984 |
Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.
Topics: Animals; Binding, Competitive; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; In Vitro Techniques; Male; Neuromuscular Junction; Obidoxime Chloride; Oximes; Pyridines; Pyridinium Compounds; Quinuclidinyl Benzilate; Rats; Sarin; Synaptic Transmission | 1994 |
Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice.
Topics: Animals; Antidotes; Chemical Warfare Agents; Cholinesterase Reactivators; Female; Gas Poisoning; Mice; Obidoxime Chloride; Organophosphate Poisoning; Organophosphorus Compounds; Oximes; Pyridinium Compounds; Sarin; Soman | 1996 |
Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterase Reactivators; Erythrocyte Aging; Erythrocytes; Humans; In Vitro Techniques; Obidoxime Chloride; Oximes; Pralidoxime Compounds; Pyridines; Pyridinium Compounds; Sarin | 2000 |
Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates.
Topics: Acetylcholinesterase; Algorithms; Animals; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Enzyme Activation; Erythrocyte Membrane; Guinea Pigs; Humans; Kinetics; Obidoxime Chloride; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridines; Pyridinium Compounds; Rabbits; Rats; Sarin; Species Specificity | 2002 |
TOXOGONIN IN SARIN, SOMAN AND TABUN POISONING.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterases; Erythrocytes; Mice; Obidoxime Chloride; Organophosphates; Oximes; Pharmacology; Phosphates; Research; Sarin; Soman; Toxicology | 1965 |
In vitro reactivation of acetylcholinesterase using the oxime K027.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Obidoxime Chloride; Organophosphates; Organothiophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Sarin; Structure-Activity Relationship | 2004 |
A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Topics: Acetylcholinesterase; Animals; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Male; Obidoxime Chloride; Organophosphates; Organophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Rats; Rats, Wistar; Sarin | 2004 |
In vitro reactivation of sarin-inhibited brain acetylcholinesterase from different species by various oximes.
Topics: Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Humans; Kinetics; Obidoxime Chloride; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Rats; Sarin; Species Specificity; Structure-Activity Relationship; Swine | 2005 |
Direct reaction of oximes with crotylsarin, cyclosarin, or VX in vitro.
Topics: Cholinesterase Inhibitors; Cholinesterase Reactivators; Decontamination; Half-Life; Kinetics; Models, Chemical; Obidoxime Chloride; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Poisoning; Pralidoxime Compounds; Pyridinium Compounds; Sarin; Spectrophotometry, Ultraviolet | 2007 |
Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Topics: Animals; Brain; Chemical Warfare Agents; Chlorpyrifos; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Obidoxime Chloride; Organophosphates; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Rats; Rats, Wistar; Sarin; Soman; Tissue Extracts; Trimedoxime | 2007 |
Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Cholinesterase Reactivators; Erythrocytes; Humans; Muscles; Obidoxime Chloride; Paraoxon; Perfusion; Sarin | 2008 |
In vitro reactivation of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing methoxy ether linkages.
Topics: Acetylcholinesterase; Animals; Chemical Phenomena; Chemistry, Physical; Cholinesterase Inhibitors; Cholinesterase Reactivators; Electrophorus; Obidoxime Chloride; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Quantitative Structure-Activity Relationship; Sarin | 2008 |
Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
Topics: Acetylcholinesterase; Animals; Antidotes; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; In Vitro Techniques; Obidoxime Chloride; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Research Design; Sarin; Swine | 2006 |
Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
Topics: Acetylcholinesterase; Antidotes; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Humans; In Vitro Techniques; Molecular Structure; Obidoxime Chloride; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Sarin; Structure-Activity Relationship | 2008 |
A structure-activity analysis of the variation in oxime efficacy against nerve agents.
Topics: Acetylcholinesterase; Animals; Atropine; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Erythrocytes; Guinea Pigs; Linear Models; Male; Obidoxime Chloride; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Sarin; Structure-Activity Relationship | 2008 |
Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Topics: Acetylcholinesterase; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Erythrocyte Membrane; Humans; Kinetics; Male; Obidoxime Chloride; Organophosphorus Compounds; Oximes; Pyridinium Compounds; Sarin | 2009 |
Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Cholinesterase Reactivators; Enzyme Activation; Humans; Kinetics; Obidoxime Chloride; Organophosphates; Oximes; Protein Binding; Pyridinium Compounds; Sarin; Structure-Activity Relationship | 2010 |
In vitro evaluation of bis-pyridinium oximes bearing methoxy alkane linker as reactivators of sarin inhibited human acetylcholinesterase.
Topics: Adult; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Erythrocyte Membrane; Humans; In Vitro Techniques; Male; Obidoxime Chloride; Pralidoxime Compounds; Sarin | 2010 |
A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Topics: Animals; Antidotes; Atropine; Autonomic Nervous System; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Czech Republic; Drug Therapy, Combination; Lethal Dose 50; Male; Muscarinic Antagonists; Neurons; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Psychomotor Performance; Pyridinium Compounds; Rats; Rats, Wistar; Sarin | 2012 |
A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Cholinesterase Reactivators; GPI-Linked Proteins; Humans; Kinetics; Obidoxime Chloride; Organophosphorus Compounds; Oximes; Pyridinium Compounds; Quantitative Structure-Activity Relationship; Recombinant Proteins; Sarin | 2013 |
A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Topics: Acetylcholinesterase; Animals; Animals, Outbred Strains; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Pyridinium Compounds; Rats, Wistar; Sarin | 2015 |
Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
Topics: Acetylcholinesterase; Cholinesterase Reactivators; Drug Therapy, Combination; Humans; Inhalation Exposure; Injections, Intramuscular; Models, Biological; Nerve Agents; Obidoxime Chloride; Organophosphates; Organophosphorus Compounds; Oximes; Pyridinium Compounds; Sarin; Toxicokinetics | 2016 |
A liquid chromatography tandem mass spectrometric method on in vitro nerve agents poisoning characterization and reactivator efficacy evaluation by determination of specific peptide adducts in acetylcholinesterase.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Cholinesterase Reactivators; Chromatography, Liquid; Colorimetry; Enzyme Activation; Humans; In Vitro Techniques; Nerve Agents; Obidoxime Chloride; Oximes; Peptide Fragments; Pralidoxime Compounds; Pyridinium Compounds; Sarin; Tandem Mass Spectrometry | 2016 |
Synthesis and in vitro reactivation study of isonicotinamide derivatives of 2-(hydroxyimino)-N-(pyridin-3-yl)acetamide as reactivators of Sarin and VX inhibited human acetylcholinesterase (hAChE).
Topics: Acetamides; Aminopyridines; Cholinesterase Inhibitors; Cholinesterase Reactivators; Erythrocyte Membrane; Humans; Kinetics; Niacinamide; Obidoxime Chloride; Organothiophosphorus Compounds; Oximes; Pralidoxime Compounds; Sarin | 2016 |
Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned mice.
Topics: Animals; Atropine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Lethal Dose 50; Male; Mice; Obidoxime Chloride; Organophosphate Poisoning; Organophosphorus Compounds; Oximes; Pyridinium Compounds; Sarin; Time Factors | 2018 |
Efficacy of atropine sulfate/obidoxime chloride co-formulation against sarin exposure in guinea pigs.
Topics: Animals; Atropine; Cholinesterase Reactivators; Cholinesterases; Dose-Response Relationship, Drug; Drug Compounding; Electroencephalography; Guinea Pigs; Injections, Subcutaneous; Male; Obidoxime Chloride; Sarin; Structure-Activity Relationship; Survival Rate | 2018 |
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Computational Biology; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Tacrine | 2008 |